Danny Tobey M.D., J.D.

• Advising numerous machine learning, robotics, and digital health companies on regulatory, liability, and risk mitigation issues
• Obtained as lead counsel for Fortune 100 company a voluntary complete dismissal with prejudice of all claims against it in federal court on the eve of filing motion to dismiss
• Successfully argued before Fifth Circuit Court of Appeals, winning affirmance of dismissal of all claims against client in a trade secrets case; opinion issued two weeks after oral argument
• Successfully represented life-sciences company as lead counsel in eight-figure dispute over acquisition
• Argued before en banc Delaware Supreme Court, winning affirmance of nearly US$1 million fee award for private equity client against bad-faith litigants; affirmed one day after oral argument by the Chief Justice writing for the full court
• Argued before Fifth Circuit Court of Appeals, winning unanimous reversal and remand on complex tax issue of first impression involving research and development tax credits; authored winning brief on remand
• Represented Medicare Administrative Contractor in defense against consolidated complaint before the US Department of Health and Human Services (HHS)
• Represented client in litigation with the US Food and Drug Administration (FDA) involving clinical trial design
• Helped obtain complete victory for pharmaceutical client in first Hatch-Waxman case in the Eastern District of Texas; used medical background to prepare scientific non-obviousness case; federal court validated all three patents and enjoined competitors from violating them; result affirmed by the Federal Circuit Court of Appeals
• Successfully defended major bank against US$19 billion alternative credit manager; handled winning first-chair argument preserving client's counterclaims for US$37.5 million; led drafting of defense motions resulting in dismissal of US$7 million of plaintiff's US$11 million in claims
• Obtained dismissal on forum-selection grounds for private equity fund in suit involving allegations of fraud and breach of contract
• Represented multiple hospitals in peer review and credentialing matters
• Representing molecular diagnostics laboratory in major reimbursement dispute with payor
• Conducted investigation for hospital system involving allegations of self-referral and anti-kickback violations
• Successfully resolved as mediator case involving allegations of self-referral and anti-kickback violations
• Obtained affirmance of complete dismissal of health privacy invasion claims against prominent media outlet in state appellate court
• Represented healthcare system in major case involving allegations of physician misconduct and reporting obligations; client found to have no liability on appeal
• Represented Quality Improvement Organization against allegations of medical malpractice invoking federal immunity
• Represented distressed lender advising on payor disputes of a portfolio hospital system and related proceedings
• Successfully defended as lead trial counsel a historic religious denomination sued by a breakaway faction in a church property case in Texas state court; obtained a multimillion-dollar (net) settlement payment to defendant-client and dismissal of all plaintiffs' claims
• Lead trial counsel for the SPCA of Texas defending against a complex probate matter; settled favorably at mediation
• Second-chaired six-week jury trial in state court defending against US$22 million fraud claim; successfully argued opposition to summary judgment, preserving the client's suit for aiding and abetting breach of fiduciary duty; examined trial witnesses, argued directed verdict and delivered portion of the closing argument
• Handled summary judgment proceedings for preeminent law-firm client, obtaining dismissal of all claims in a breach of contract suit
• Obtained denial of petition for review by Texas Supreme Court for prominent New York law firm, leaving in place reversal and rendition of dismissal by Dallas Court of Appeals
• Led briefing before Fifth Circuit Court of Appeals, winning affirmance in pertinent part of plaintiff investment firm's summary judgment win on claims of fraudulent transfer and piercing the corporate veil (monetary damages)

The Legal 500 United States

• Recommended, Healthcare: Life Sciences, 2020
  The Legal 500 comments, "Danny Tobey and Lukas Pryzmusinski are physicians in addition to being lawyers which enhances their ability to serve life sciences clients."
• Recommended, Healthcare: Service Providers, 2020

Additional Recognitions

• Financial Times' Innovative Practitioner in 2023
• Insider's 2022 list of the top attorneys helping companies adopt AI
• Named a Fellow of the Texas Bar Foundation
• Selected to the Texas Rising Stars list, Super Lawyers (Thomson Reuters), 2012–2016
• Cardozo Society, "Outstanding Attorney Under 40," 2012–2015

• Quoted, "Law firm use of data scientists grows alongside AI's challenges," CQ - Roll Call, November 5, 2024
• Co-author, "A Look At Calif.'s New AI Law For Health Insurers," Law360, October 15, 2024
• Author, "Recent Securities Cases Highlight Risks in AI Disclosures," Law360, October 9, 2024
• Author, "How In-House Legal Departments Should Engage with Generative AI," Bloomberg Law, September 6, 2024
• Quoted, "DLA Piper Audits the Robots as Big Law Digs into AI Work," Bloomberg Law, December 13, 2023
• Author, "Law Firms of the Future Will Be Different in Three Critical Ways," Bloomberg Law, August 21, 2023
• Author, "Organizational Governance of Emerging Technologies: AI Adoption in Healthcare," arXiv, April 25, 2023 (prepublication draft), accepted to the Association for Computing Machinery (ACM)’s 2023 Conference on Fairness, Accountability, and Transparency
• "Contributed: The Rise of Femtech," MobiHealthNews, December 11, 2020
• Author, "Lessons Learned About Autonomous AI: Finding a Safe, Efficacious, and Ethical Path Through the Development Process," American Journal of Ophthalmology, March 12, 2020
• "Medical Frontiers in AI Liability," American Health Lawyers Association Magazine, February 2020
• Author, "AI For GCs: What You Need to Know as Your Company Adapts,"ACC Docket, March 2019
• Author, "Explainability: Where AI And Liability Meet," Law360, February 2019
• Author, "Software Malpractice in the Age of AI," 2018 Proceedings of the Association for the Advancement of AI, February 2018
• Author, "AI is Here, Is Your Company Ready? (Hint: No),"National Law Journal, December 2017
• Danny is a former Literature Editor of the Harvard Lampoon, a published novelist and a former copywriter at a Madison Avenue advertising agency. His writing on AI and other legal issues appears in the National Law Journal, the 2018 AAAI Proceedings on Artificial Intelligence, Health Law Litigation and the Yale Journal of Law & Technology.

• Presenter, "The Impact of Artificial Intelligence on International Arbitration "AI? What is it?""ICC Institute of World Business Law Annual Conference, November 12, 2024
• Workshop, "Driving Innovation in the Face of the EU AI Act," Financial Times Future of AI Summit, November 7, 2024
• Roundtable, "Building Trustworthy AI at Scale: How to create value from a fair and transparent system," Financial Times Future of AI Summit, November 7, 2024
• Panelist, "The rapidly evolving global AI regulatory landscape - Balancing innovation and competition," Financial Times Future of AI Summit, November 6, 2024 
• Panelist, "AI: unlocking the future of the Life Sciences industry," DLA Piper Global Life Sciences Summit, November 6, 2024
• Panelist, "Artificial Intelligence: Innovations and Regulations in the Entertainment World", USC Gould School of Law-Beverly Hills Bar Association's Institute on Entertainment Law and Business, October 19, 2024
• Speaker, "Responsible AI: An Ethical Grounding for General Counsels," Wall Street Journal’s The Modern GC: Navigating Artificial Intelligence, October 10, 2024
• Panelist, "Navigating the AI Regulatory Landscape," alongside speakers from SEC and FINRA, Compliance Week AI & Compliance Summit, October 8, 2024
• Moderator, "The Latest and Greatest in AI Governance Frameworks—and the Interplay with Privacy and GDPR Compliance Structures: Concrete Examples and Lessons Learned," AI Law, Ethics, Safety & Compliance Conference, September 26, 2024 
  
• Panelist, "Innovative Teaming: The New Role of AI," Global Women's Leadership Summit, September 18, 2024
• Presenter, "Addressing Legal Risks in GenAI: The Importance of Legal Red Teaming," July 25, 2024
• Panelist, "Oxford Future of Professionals Roundtable," Saïd Business School, University of Oxford, June 26, 2024
• Panelist, "Emerging Trends in Artificial Intelligence Adoption," ACFE Global Fraud Conference, Las Vegas, June 24, 2024
• Moderator, "AI for Good: Corporate Trailblazers," UN AI for Good Global Summit, Geneva, Switzerland, May 31, 2024
• Speaker, "AI Summit: Balancing Growth and Governance," Mandarin Oriental, Miami, May 14-15, 2024
• Speaker, "2024 CodeX FutureLaw conference," The Stanford Center for Legal Informatics, April 11, 2024
• Panelist, "Creating AI Tools for Tomorrow: Harnessing AI For Dispute Avoidance, and Effective Dispute Resolution," International Institute for Conflict Prevention & Resolution Annual Meeting, March 8, 2024
• Co-Chair of ACI's inaugural Life Sciences AI Summit, February 2024
• Speaker, "Ethics & Technology: The Evolving Practice of Law and Your Ethical Responsibilities," 43rd Annual Ray Garrett Jr. Corporate & Securities Law Institute, October 5, 2023
• Invited Speaker, "NACD Master Class® on AI's Impact on Strategy and the Board," moderated by Karim Lakhani, Harvard Business School; Chair, D3 Institute at Harvard; Director, Mozilla, August 21, 2023
• Speaker, "Council of Public Funds Compliance Officers call on Emerging Standards in AI Governance," July 31, 2023
• Invited Panelist, "AI and the AG," AG Alliance Annual Meeting, moderated by Attorney General Kris Kobach, Kansas, June 20, 2023
• Presenter, "Private Attorneys General Act (PAGA) Claims, Appeals, and Efforts to Reform the Law," the National Retail Federation, June 7, 2023
• Presenter, "Tech & Trade Forum in Seoul," the Korea Chamber of Commerce and Industry, May 9, 2023
• Speaker, "The Intersection of Law and Artificial Intelligence," Eye on AI #121, April 28, 2023
• Speaker, "Adaptive Law: What Will Regulation Become?" CodeX Futurelaw Conference 2023," The Stanford Center for Legal Informatics, April 13, 2023
• Speaker, "Legal Framework of AI in the United States, Swissnex New York and Boston," Swiss Embassy in the U.S., March 10, 2023
• Moderator, "AI: Opportunities and Challenges, panel of FICO and others, Structured Finance Association’s SFVegas," February 26 - March 1, 2023
• Moderator, "Leveraging the Private Sector to Reach Health Security Goals in Africa," on the sidelines of the 2022 U.S.-Africa Leaders Summit, January 09, 2023
• Moderator, "Fireside Chat on Improving Health Security in Africa through Strategic Partnership," US-Africa Leaders’ Summit, December 13, 2022
• Moderator, "Ministerial Roundtable on Improving Health Outcomes in Africa through Innovative Solutions," July 2022
• Moderator, "Advancing Patient Outcomes Through Partnerships," Disease Foundation Forum, March 21, 2022
• Invited Panelist, "Explainable AI," UTA, 6th Annual Business Analytics Symposium, March 3, 2022
• Moderator, "Advances in Healthcare Technology – Cure or Cause?" International Institute for Conflict Prevention & Resolution, Annual Meeting 2022, March 3, 2022
• Panelist, "Machine Learning & AI for Healthcare," HIMSS Conference, December 14-15, 2021
• Panelist, "Healthy vs Hype: The State of AI in Healthcare," August 30th, 2020
• Speaker, "Artificial Intelligence and Health Care: The Intersection of Science and Law," WCL, July 8, 2020
• Panelist: "The People vs. OJ Simpson: Strategy Lessons from the Trial of the Century," February 2020
• Panelist: "Effective Motion Presentation for the Busy Trial Court: Drafting and Oral Arguments," February 2020
• Moderator, "Fireside Chat with Dr. Amy Abernethy," Principal Deputy Commissioner of the US Food and Drug Administration, Texas Israel Life Sciences and Healthcare Innovation Conference, October 25, 2019
• Distinguished Speaker, "Texas Analytics Summit 2019," Sponsored by Dell, McCombs School of Business, University of Texas, "Streamline Your Legal and Privacy Approach to AI" October 17-18, 2019
• Speaker, "Texas Analytics Summit," October 2019
• Speaker, "Streamline Your Legal and Privacy Approach to AI," Xavier AI Summit, August 2019
• Moderator, "Raising Funds for Your Medical Device Company," Biocom's DeviceFest & Digital Health Conference, Moderator, Correlation Ventures, GTCR, August 2019
• Moderator, "AI is Everywhere: A Sector-by-Sector discussion regarding the Opportunities and Challenges with Artificial Intelligence," Healthcare: Novartis, IBM Watson Health, Athenahealth, IDx, Suffolk Law School, June 2019
• Faculty, TMXc Accelerator, Texas Medical Center, "Digital Health Regulation," February 25, 2019, with Kristi Kung
• "Fireside Chat," Duke Institute for Health Innovation, December 3, 2018
• Presenter, "Mitigating Legal Risks in Digital Health Adoption," with Kristi Kung, November 13, 2018
• Presenter, "Emerging Medical and Legal Issues in AI," October 7, 2018
• Presenter, "Email Through the Eyes of Judges and Juries"

• "A research team airs the messy truth about AI in medicine — and gives hospitals a guide to fix it," April 2023
• "Law Firm DLA Piper Poaches Data Scientists to Capitalize on AI Boom" Financial Times, March 2023
• "Accountable AI Is Here to Stay and Big Law Has Taken Notice" American Lawyer, March 2023
• "How AI Is Reshaping the Way Moves Are Made" Fortune, Feb 2023
• "EU, US Making Moves to Address Ethics in AI" EETimes, Jan 2023
• "How Does the White House AI Bill of Rights Apply to Healthcare?" HealthIT Analytics, Dec 2022
• "Business Leaders Are Still Nervous About the Side Effects of AI," Forbes, Dec 2022 
• "Meet the Top 8 Lawyers Helping Startups Patent AI," Business Insider, July 2022
• "ScaleUp AI 2022: Risks of ‘Wild West’ AI in Health Care," IOTWorldToday, April 7, 2022
• "AI in Healthcare Presents Need for Security, Privacy Standards," HealthITSecurity, February 17, 2022
• "Duke, Mayo Clinic, others launch innovative AI collaboration," HIMSS, December 14, 2021
• "LaunchBio Partners With DLA Piper to Accelerate North Texas as a Hub for Life Science Startups," Dallas Innovates, February 10, 2021
• "How Biden and Harris could refocus the White House on science," Engadget, January 25, 2021
• "Covid-19 has let digital health prove itself," Globes, September 21, 2020
• Podcast, "Digital health: Connecting patients and services in a COVID-19 world," DLA Piper, July 13, 2020
• "AI-Related Lawsuits Are Coming," SHRM, November 1, 2019
• "Listen: Developing AI Tech Can Mean Walking Through A Patient Privacy Mine," Medtech Insight, September 13, 2019
• Podcast, "Listen: Developing AI Tech Can Mean Walking Through A Patient Privacy Mine," Medtech Insight, September 13, 2019
• "AT&T Performing Arts Center Board Names News Chair-Elect and Directors ," Dallas Weekly, September 7, 2019
• "AI Technology And Navigating The HIPAA Minefield," MedTech Insight, September 13, 2019
• "DLA Piper Announces New Artificial Intelligence Practice," Law360, May 2019

• AT&T Performing Arts Center – Chair of the Board (2021–present); Chair-Elect (2019–2021); Board of Directors, 2016–present (Executive Committee, 2018–present)
• Parkland Foundation - Board of Directors, 2016–present (Executive Committee, 2017–present); Capital Campaign Steering Committee, 2013–2015
• SPCA of Texas - Board of Directors, 2016–2019
• Perot Museum of Nature and Science – Board of Directors, 2016–present (Chair, Legal Advisory Committee (2019–present), Executive Committee (2019–present)); Museum Board, 2013–2016; Legal Advisory Committee, 2013–present; Advisory Board, 2012–2013
• Anti-Defamation League, Texoma region – Board of Directors, 2017–present
• Dallas Bar Association - Judiciary Committee, 2012–present; Co-Chair, 2016; Admissions and Membership Committee, 2013–present; Co-Chair, 2018; Governing Council, Business Litigation Section 2018–present
• Texas Israel Alliance (Board of Directors, 2019–present)
• Harvard Club of Dallas - Harvard Schools Committee, Interviewer, 2003–present
• Leadership Arts Institute - Business Council for the Arts, Leadership Class of 2011–2012